BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2017
View Archived Issues
Identification of AAT-008, a potent and selective prostaglandin EP4 receptor antagonist
Read More
FDA awards orphan drug designation to Moleculin's liposomal annamycin for AML
Read More
RL-71 shows promise in suppressing tumor growth in triple-negative breast cancer mouse model
Read More
Pfizer initiates phase II study of PF-06741086 in severe hemophilia
Read More
EMA accepts for review brexpiprazole MAA for schizophrenia in adults
Read More
EMA grants orphan drug designation to NiCord in HSCT
Read More
BioLineRx acquires Agalimmune
Read More
Herantis gets Swedish clearance to begin phase I/II trial of CDNF in Parkinson's disease
Read More
Toxicity and pharmacokinetics of myocardial infarction candidate RUC-4 studied in vivo
Read More
Merck & Co. initiates phase IIa study of MK-8189 in schizophrenia
Read More
Janssen identifies novel cannabinoid receptor 1 inverse agonists
Read More
Pharmacokinetic and pharmacodynamic data presented from first clinical trial of BMS-962212
Read More
Santen Pharmaceutical patents glucocorticoid receptor agonists
Read More
Janssen Pharmaceutica synthesizes novel analgesic compounds
Read More
Bristol-Myers Squibb synthesizes novel myeloperoxidase and/or eosinophil peroxidase inhibitors
Read More
Ocean University of China describes new anti-HSV-1 compounds
Read More
ImmunoCellular Therapeutics and Memgen sign immuno-oncology collaboration letter of intent
Read More
NR4A1, a novel target for the treatment of alveolar rhabdomyosarcoma
Read More
FDA approves Bavencio for metastatic Merkel cell carcinoma
Read More
European Commission approves Amgen's adalimumab biosimilar Amgevita
Read More
Torii seeks to expand Japanese label for Miticure to include pediatric patients
Read More
FDA grants breakthrough therapy designation to Rituxan for pemphigus vulgaris
Read More
Merrimack initiates phase I study of MM-310 in solid tumors
Read More
FDA accepts for filing Solosec NDA for bacterial vaginosis
Read More
FDA approves Symproic for opioid-induced constipation in adults with chronic non-cancer pain
Read More
IDMC recommends continuation of phase II/III trial of NBTXR-3 in soft tissue sarcoma
Read More